Stay updated with breaking news from Oral Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bayer is voluntarily recalling one lot of Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles to the consumer/user level. The product is being recalled due to microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing.
Bayer is recalling 1 lot of Vitrakvi (larotrectinib) Oral Solution 20mg/mL due to the presence of microbial contamination.
WHIPPANY, N.J.--(BUSINESS WIRE)--Nov 17, 2023--
Kye Pharmaceuticals Inc. ("Kye"), a Canadian specialty pharmaceutical company, announced its partnership with Hyloris Pharmaceuticals SA ("Hyloris"), a Belgium-based developer, manufacturer and global supplier of a novel, prescription, oral solution form of atomoxetine. Through this partnership, Kye becomes the exclusive Canadian rights holder for the Atomoxetine Oral Solution developed by Hyloris. Under the terms of the agreement, Kye is responsible for the registration and commercialization of
This article discusses how ion chromatography can be used to quantify chloride content in oral tablets.